CS182792B2 - Method of production of 2,6-diaminodihydropyridines - Google Patents
Method of production of 2,6-diaminodihydropyridinesInfo
- Publication number
- CS182792B2 CS182792B2 CS7500003602A CS360275A CS182792B2 CS 182792 B2 CS182792 B2 CS 182792B2 CS 7500003602 A CS7500003602 A CS 7500003602A CS 360275 A CS360275 A CS 360275A CS 182792 B2 CS182792 B2 CS 182792B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- diaminodihydropyridines
- production
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2210687A DE2210687C3 (en) | 1972-03-06 | 1972-03-06 | 2,6-diamino-3,5-diethoxycarbonyldihydropyridines, process for their preparation and pharmaceuticals containing them |
Publications (1)
Publication Number | Publication Date |
---|---|
CS182792B2 true CS182792B2 (en) | 1978-05-31 |
Family
ID=5838037
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS7300001593A CS182781B2 (en) | 1972-03-06 | 1973-03-06 | Method of producing 2,6-diaminodihydropyridines |
CS7500003602A CS182792B2 (en) | 1972-03-06 | 1973-03-06 | Method of production of 2,6-diaminodihydropyridines |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS7300001593A CS182781B2 (en) | 1972-03-06 | 1973-03-06 | Method of producing 2,6-diaminodihydropyridines |
Country Status (24)
Country | Link |
---|---|
JP (2) | JPS5626659B2 (en) |
KR (1) | KR780000119B1 (en) |
AT (3) | AT327904B (en) |
BE (1) | BE796279A (en) |
BG (2) | BG20583A3 (en) |
CA (1) | CA988524A (en) |
CH (2) | CH580589A5 (en) |
CS (2) | CS182781B2 (en) |
DD (1) | DD106833A5 (en) |
DE (1) | DE2210687C3 (en) |
DK (1) | DK136061C (en) |
ES (1) | ES412323A1 (en) |
FI (1) | FI55996C (en) |
FR (1) | FR2181789B1 (en) |
GB (1) | GB1379005A (en) |
HU (1) | HU167089B (en) |
IE (1) | IE37370B1 (en) |
IL (1) | IL41664A (en) |
LU (1) | LU67147A1 (en) |
NL (1) | NL7303137A (en) |
PL (2) | PL92078B1 (en) |
RO (2) | RO61192A (en) |
SE (1) | SE384208B (en) |
ZA (1) | ZA731501B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2210687C3 (en) * | 1972-03-06 | 1981-09-24 | Bayer Ag, 5090 Leverkusen | 2,6-diamino-3,5-diethoxycarbonyldihydropyridines, process for their preparation and pharmaceuticals containing them |
DE2406198C2 (en) * | 1974-02-09 | 1983-12-15 | Bayer Ag, 5090 Leverkusen | Process for the preparation of new 2-amino-6-dialkylamino-dihydropyridines |
JPS5922593U (en) * | 1982-08-03 | 1984-02-10 | 日本マランツ株式会社 | Horn mounting structure for headphone |
JPS5922594U (en) * | 1982-08-03 | 1984-02-10 | 日本マランツ株式会社 | earplug type headphone |
JPS6282898A (en) * | 1985-10-08 | 1987-04-16 | Matsushita Electric Ind Co Ltd | Headphone |
JPS6293060U (en) * | 1985-11-28 | 1987-06-13 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3855231A (en) * | 1972-03-06 | 1974-12-17 | Bayer Ag | 2,6-diamino-1,4-dihydropyridine derivatives |
DE2210687C3 (en) * | 1972-03-06 | 1981-09-24 | Bayer Ag, 5090 Leverkusen | 2,6-diamino-3,5-diethoxycarbonyldihydropyridines, process for their preparation and pharmaceuticals containing them |
DE2406198C2 (en) * | 1974-02-09 | 1983-12-15 | Bayer Ag, 5090 Leverkusen | Process for the preparation of new 2-amino-6-dialkylamino-dihydropyridines |
-
1972
- 1972-03-06 DE DE2210687A patent/DE2210687C3/en not_active Expired
-
1973
- 1973-02-13 RO RO73832A patent/RO61192A/ro unknown
- 1973-02-13 RO RO7300082647A patent/RO63068A/ro unknown
- 1973-02-26 DD DD169048A patent/DD106833A5/xx unknown
- 1973-02-28 BG BG024472A patent/BG20583A3/en unknown
- 1973-02-28 BG BG022858A patent/BG22815A3/en unknown
- 1973-03-02 LU LU67147A patent/LU67147A1/xx unknown
- 1973-03-02 JP JP2445273A patent/JPS5626659B2/ja not_active Expired
- 1973-03-02 IL IL7341664A patent/IL41664A/en unknown
- 1973-03-02 CH CH313273A patent/CH580589A5/xx not_active IP Right Cessation
- 1973-03-02 FI FI657/73A patent/FI55996C/en active
- 1973-03-02 CH CH220176A patent/CH577473A5/xx not_active IP Right Cessation
- 1973-03-03 PL PL1973182270A patent/PL92078B1/pl unknown
- 1973-03-03 PL PL1973161010A patent/PL89256B1/pl unknown
- 1973-03-05 BE BE128374A patent/BE796279A/en not_active IP Right Cessation
- 1973-03-05 CA CA165,209A patent/CA988524A/en not_active Expired
- 1973-03-05 KR KR7300356A patent/KR780000119B1/en active
- 1973-03-05 IE IE346/73A patent/IE37370B1/en unknown
- 1973-03-05 ES ES412323A patent/ES412323A1/en not_active Expired
- 1973-03-05 SE SE7303021A patent/SE384208B/en unknown
- 1973-03-05 DK DK118073A patent/DK136061C/en active
- 1973-03-05 ZA ZA731501A patent/ZA731501B/en unknown
- 1973-03-06 CS CS7300001593A patent/CS182781B2/en unknown
- 1973-03-06 GB GB1075973A patent/GB1379005A/en not_active Expired
- 1973-03-06 FR FR7307923A patent/FR2181789B1/fr not_active Expired
- 1973-03-06 AT AT925774*7A patent/AT327904B/en not_active IP Right Cessation
- 1973-03-06 AT AT197373A patent/AT324338B/en not_active IP Right Cessation
- 1973-03-06 AT AT925774A patent/ATA925774A/en unknown
- 1973-03-06 CS CS7500003602A patent/CS182792B2/en unknown
- 1973-03-06 NL NL7303137A patent/NL7303137A/xx not_active Application Discontinuation
- 1973-03-06 HU HUBA2892A patent/HU167089B/hu unknown
-
1980
- 1980-12-27 JP JP55185147A patent/JPS5911584B2/en not_active Expired
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CS179404B2 (en) | Method for production of 1,1,2,3,-tetrachlorpropene | |
CS171705B2 (en) | Method of new antibiotic 3,'4'-dideoxycanamicine b production | |
CS182793B2 (en) | Method for production of substituted ce-pentanorprostaglandins | |
CS183675B2 (en) | Method of producing new benzo-1,2,4-triazin-di-n-oxides/1,4/ | |
CS183686B2 (en) | Method of producing 1-hydroxy-2-pyridones | |
CS182260B2 (en) | Method of producing 1,3-oxidated 8alfa-estratrienes | |
CS183721B2 (en) | Method of production of alfa-aminoacylcephalosporines | |
CA1023766A (en) | Process for the production of 3-halogen- and 3,5-dihalogen-phenols | |
CS171232B2 (en) | Method of 2,2-diaryl-4-(4'-aryl-4'-hydroxypiperidino) butyramides production | |
GB1402501A (en) | Process for the production of 4-nitroso-diphenylamine | |
CS182248B2 (en) | Method of producing n-benzhydryl-n-p-hydroxy-benzylpiperazine | |
CS182792B2 (en) | Method of production of 2,6-diaminodihydropyridines | |
IL41815A (en) | Process for the production of 2,5-dichloro-3-nitro-benzoic acid | |
CS192504B2 (en) | Method of producing cyano-methyl-thioacetyl-cephalosporins | |
CS191212B2 (en) | Method of producing lysergamides | |
CS193475B2 (en) | Method of producing derivatives of 2beta,16 beta-bispiperazino-andrestane | |
CS181731B2 (en) | Method of producing new derivatives of 2,10-dichlor-12h-dibenzo/d,g//1,3/dioxocine | |
JPS5217466A (en) | Production of 55 benzoylindolinee22one | |
IL43478A0 (en) | Process for the manufacture of 9,10-seco-oestrane derivatives | |
CS193477B2 (en) | Method of producing 15 alpha,16 alpha-methylene-4-pregnenes | |
CS179035B1 (en) | Method for production of 2',3'-didesoxy-3'-fluorpyrimidine-nucleosides | |
GB1407529A (en) | 1,2-dihydroindene-2-spiro-2-piperazine derivatives and process for production thereof | |
ZA734672B (en) | Method for the production of polychromatically active thiazine-eosinates | |
CS179414B2 (en) | Process for production of anthraquinone. | |
ZA737199B (en) | Process for the production of 2-nitro-benzofurans |